Charles Sternberg, Associate Editor01.05.23
Life Science Outsourcing Inc. (LSO), a contract manufacturer and value-added service provider to medical device and life science companies, has acquired J-Pac Medical, a manufacturing, packaging and sterilization outsourcing partner to medical device and diagnostic companies.
Headquartered in Somersworth, NH, J-Pac Medical has more than 35 years of experience providing market-ready and customized solutions to meet the needs of early stage and established OEMs. J-Pac Medical's experience in complex thermoplastic devices, packaging and in-house tooling capabilities allows it to manufacture anatomically correct, class III implantable textile assemblies, lab-on-chip reagent blisters and complicated thermoformed packaging.
As such, the company has established a strong presence in the implantable medical textiles and diagnostics end-markets. J-Pac Medical operates a 60,000 sq. ft. ISO 13485 certified and FDA registered facility with cleanroom capabilities in New Hampshire and has strong supplier relationships in Costa Rica. J-Pac Medical partners with its customers to offer effective onshore and managed nearshore solutions.
"J-Pac Medical's technical know-how and production experience around reagent blister packaging in the molecular diagnostics end-market represents an exciting growth opportunity given trends in point-of-care diagnostics, specifically as it relates to microfluidics and lab-on-a-chip applications. Our partnership with LSO broadens our reach within the life sciences and diagnostics end-markets we are targeting," remarked Jeff Barrett, president of the newly formed Diagnostics Division.
Asif Zaman, partner and head of Healthcare Services at PPC, which acquired LSO in 2021, commented, "The combination realizes our vision of building LSO into a truly national platform that provides post-manufacturing and regulated services to early stage and established players in the growing med-tech and diagnostics end-markets.”
"The combination of LSO and J-Pac Medical allow us to provide a wider array of services to our customers across an even broader geographic footprint. This should allow a greater number of medical device and diagnostic organizations to accelerate their development and manufacturing capabilities," added John Morgan, an operating partner at PPC.
Headquartered in Somersworth, NH, J-Pac Medical has more than 35 years of experience providing market-ready and customized solutions to meet the needs of early stage and established OEMs. J-Pac Medical's experience in complex thermoplastic devices, packaging and in-house tooling capabilities allows it to manufacture anatomically correct, class III implantable textile assemblies, lab-on-chip reagent blisters and complicated thermoformed packaging.
As such, the company has established a strong presence in the implantable medical textiles and diagnostics end-markets. J-Pac Medical operates a 60,000 sq. ft. ISO 13485 certified and FDA registered facility with cleanroom capabilities in New Hampshire and has strong supplier relationships in Costa Rica. J-Pac Medical partners with its customers to offer effective onshore and managed nearshore solutions.
Comments from Leadership
"J-Pac Medical stood out as a unique and attractive business that aligned perfectly with LSO's strategic and commercial objectives. The company's capabilities in reagent blister packaging, thermoforming and biomaterials will be additive to LSO's existing customer base. J-Pac Medical's assembly, packaging and sterilization capabilities are complimentary to LSO and both will be strengthened by this truly synergistic alliance," said John Nino, CEO of LSO."J-Pac Medical's technical know-how and production experience around reagent blister packaging in the molecular diagnostics end-market represents an exciting growth opportunity given trends in point-of-care diagnostics, specifically as it relates to microfluidics and lab-on-a-chip applications. Our partnership with LSO broadens our reach within the life sciences and diagnostics end-markets we are targeting," remarked Jeff Barrett, president of the newly formed Diagnostics Division.
Asif Zaman, partner and head of Healthcare Services at PPC, which acquired LSO in 2021, commented, "The combination realizes our vision of building LSO into a truly national platform that provides post-manufacturing and regulated services to early stage and established players in the growing med-tech and diagnostics end-markets.”
"The combination of LSO and J-Pac Medical allow us to provide a wider array of services to our customers across an even broader geographic footprint. This should allow a greater number of medical device and diagnostic organizations to accelerate their development and manufacturing capabilities," added John Morgan, an operating partner at PPC.
